Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stem Cells of Arabia is a biotechnology and regenerative medicine company headquartered in Amman, Jordan, specializing in the clinical application and research of adult stem cell therapies. Founded and led by Dr. Adeeb Al-Zoubi, the company focuses on treating chronic and previously incurable diseases using autologous and allogeneic stem cell transplantations. Their services encompass a wide range of medical conditions, including neurological disorders, autoimmune diseases, and metabolic syndromes such as diabetes. The organization operates state-of-the-art laboratories for stem cell isolation, purification, and characterization, positioning itself as a leading center for regenerative medicine in the Middle East.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stem Cells of Arabia.